ZICCUM AB interim report January 1-September 30, 2020
Summary of interim report, third quarter 2020 During the third quarter Ziccum made great progress in its work of industrializing its unique process for producing vaccines in dry powder form. Major economic and production-technical advantages have been demonstrated, as well as the fact that dry vaccines offer a significantly simplified and cost-effective logistics chain.Jul-Sep 2020 Net sales SEK 0 KSEK (0) Operating profit -5,317 KSEK (-1,380) Earnings per share before and after dilution -0.56 SEK (-0.23) Jan-Sep 2020 Net sales 0 KSEK (0) Operating profit -14,006 KSEK (-